Dermatan sulfate enhances the lysis of laser-induced thrombus in vivo

Thrombosis Research

Volumn 91, Issue 4, 1998, Pages 199-202

  Krupinski, Kazimiez ^a   Bielawiec, Michael ^a   Yoshida, Keiichi ^b   Kyogashima, M ^b   Takada, Yumiko ^c   Takada, Akikazu ^c  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Seikagaku Kogyo   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Clot lysis; Dermatan sulfate; Thrombus; Tissue plasminogen activator

Indexed keywords

DERMATAN SULFATE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL MODEL; ARGON LASER; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOGENESIS; THROMBOSIS; THROMBOSIS PREVENTION;

ANIMALS; ANTICOAGULANTS; DERMATAN SULFATE; INJECTIONS, INTRAPERITONEAL; LASERS; MALE; RATS; RATS, WISTAR; THROMBOSIS;

EID: 0032529062     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(98)00077-2     Document Type: Article

References (19)

1. Mascellani G., Liverani L., Bianchini P., Parma B., Torri G., Bisio A., Guerrini M., Casu B. Structure and contribution to the HCII-mediated inhibition of thrombin of naturally oversulphated sequences of dermatan sulphate. Biochem J. 296:1993;639-648.
2. Mascellani G., Liverani L., Prete A., Guppola P.L., Bergonzini G.L., Bianchini P. Relative influence of different disulphate disaccharide clusters on the HCII-mediated inhibition of thrombin by dermatan sulphates of different origins. Thromb Res. 74:1994;605-615.
3. Mascellani G., Liverani L., Parma B., Bergonsini G.L., Bianchini P. Active site for heparin cofactor II in low molecular mass dermatan sulfate. Contribution to the antithrombotic activity of fractions with high affinity for heparin cofactor II. Thromb Res. 84:1996;21-32.
4. Weichert W., Pauliks V., Breddin H.K. Laser-induced thrombi in rat mesenteric vessels and antithrombotic drugs. Haemostas. 13:1983;61-71.
5. Weichert W., Breddin H.K. Effect of low molecular weight heparins on laser-induced thrombus formation in rat mesenteric vessels. Haemostas. 18(Suppl2):1988;55-63.
6. Tollefsen D.M., Pestka C.A., Monafo W.J. Activation of heparin cofactor II by dermatan sulfate. J Biol Chem. 258:1983;6713-6716.
7. Rosenberg R.D., Armand G., Lam L. Structure-function relationships of heparin species. Proc Natl Acad Sci USA. 75:1978;3065-3069.
8. Bendayan P., Boccalon H., Dupouy D., Boneu B. Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins. Thromb Haemost. 71:1994;576-580.
9. Fernandez F., Van Ryn J., Ofosu F.A., Hirsh J., Buchanan M.R. The haemorrhagic and antithrombotic effects of dermatan sulfate. Br J Haematol. 64:1986;309-317.
10. Maggi A., Abbadini M., Pagella P.G., Borowska A., Pangrazzi J., Donati M.B. Antithrombotic properties of dermatan sulphate in a rat venous thrombosis model. Haemostas. 17:1987;329-335.
11. Merton R.E., Thomas D.P. Experimental studies on the relative efficacy of dermatan sulphate and heparin as antithrombotic agent. Thromb Haemost. 58:1987;839-842.
12. Agnelli G., Cosmi B., Fillipo P., Ranucci V., Veschi F., Longetti M., Renga C., Barzi F., Gianese F., Lupatteli L., Rinonapeli E., Nenci G.G. A randomized, double-blind, placebo-controlled trial of dermatan sulfate for prevention of deep vein thrombosis in hip fracture. Thromb Haemost. 67:1992;203-208.
13. Prandoni P., Meduri F., Cuppini S., Toniato A., Zangrandi F., Polistena P., Gianese F., Maffei Faccioli A. Dermatan sulfate. A safe approach to prevention of postoperative deep vein thrombosis Br J Surg. 79:1992;505-509.
14. Ryan K.E., Lane D.A., Flynn A., Ireland H., Boisclair M., Shepperd J., Curtis J.R. Antithrombotic properties of dermatan sulphate (MF 701) in haemodialysis for chronic renal failure. Thromb Haemost. 68:1992;563-569.
15. Cohen A.T., Phillips M.J., Edmondson R.A., Skinner J.A., Das S.K., Cooper D.J., Thomas E., Melissari E., Kakkar V.V. A dose ranging study to evaluate dermatan sulphate in preventing deep vein thrombosis following total hip arthroplasty. Thromb Haemost. 72:1994;793-798.
16. Markwardt F., Klocking H.P. Heparin-induced release of plasminogen activator. Haemostas. 6:1977;370-374.
17. Abbadini M., Zhu G.J., Maggi A., Pangrazzi J., Benedetta M., Mussoni L. Dermatan sulphate induces plasminogen activator release in the perfused rat hindquarters. Blood. 70:1987;1858-1860.
18. Krupinski K., Breddin H.K., Casu B. Anticoagulant and antithrombotic effects of chemically modified heparins and pentosanpolysulfate. Haemostas. 20:1990;81-92.
19. Takada Y., Urano T., Takahashi H., Nagai N., Takada A. Effects of electric footshock and water immersion restraint stresses on fibrinolytic parameters in the plasma of rats. Thromb Res. 89:1998;107-114.